(A) Except as set out in this rule, for
purposes of section 3701.14 of the Revised Code, the Ohio department of health
adopts, by reference, the following tuberculosis standards:
(1) All tuberculosis
reference materials can be found on the United States centers for disease
control and prevention's website at
(2) The recommendations
of the United States centers for disease control and prevention as set out in
"Core Curriculum on Tuberculosis: What Every Clinician Should Know."
The "Core Curriculum" may be found at
(3) The recommendations of the United
States centers for disease control and prevention, the American thoracic
society, and infectious diseases society of America as set out in
"Treatment of Drug-Susceptible Tuberculosis," " Clinical
Infectious Diseases," 2016; 63(7):e147-95.
(4) The recommendations of the United
States centers for disease control and prevention as set out in "Targeted
Tuberculin Testing and Treatment of Latent Tuberculosis Infection,"
"Morbidity and Mortality Weekly Report: Recommendations and Reports, Vol.
49, No. RR-6, June 9, 2000," as modified by "Update of
Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat
Latent Mycobacterium Tuberculosis Infection," "Morbidity and
Mortality Weekly Report": June 29, 2018/67(25); 723-726.
(5) The recommendations of the United
States centers for disease control and prevention as set out in
"Guidelines for Preventing the Transmission of Mycobacterium tuberculosis
in Health-Care Setting," 2005, "Morbidity and Mortality Weekly
Report": December 30, 2005/54(RR17); 1-141, as modified by
"Tuberculosis Screening Testing, and Treatment of U.S. Health-Care
Personnel: Recommendations from the National Tuberculosis Controllers
Association and CDC, 2019," "Morbidity and Mortality Weekly
Report": May 17, 2019/68(19); 439-443.
(B) Except as set out in paragraph (A) of
this rule, the standards for performing tuberculosis screenings shall be as
(1) Decisions related to
tuberculosis screening activities shall be based on local epidemiologic data
identifying groups at risk of tuberculosis infection.
(2) Health care agencies
or other facilities shall consult with the local tuberculosis control unit
before starting a tuberculosis screening program to ensure that adequate
provisions are made for the evaluation and treatment of persons whose
tuberculin skin test or blood assay for Mycobacterium tuberculosis (BAMT) are
(C) Except as set out in paragraph (A) of
this rule, the standard for performing examinations of individuals who have
been exposed to tuberculosis and individuals who are suspected of having
tuberculosis shall be as follows:
(1) The standard
examination method for identifying persons with latent tuberculosis infection
is the Mantoux tuberculin skin test or BAMT.
(2) The standard
examination method for identifying persons with active tuberculosis
(a) A medical history;
(b) A physical examination;
(c) A Mantoux tuberculin skin test, or BAMT;
(d) A chest radiograph;
(e) Specimens collected for bacteriologic or histologic
(D) Except as set out in paragraph (A) of
this rule, the standard for providing treatment for individuals with
tuberculosis shall be as follows:
(1) A specific treatment
and monitoring plan shall be developed in collaboration with the local
tuberculosis control unit within one week of the presumptive
(2) The plan shall
include a description of an approved course of therapy, the methods of
assessing and ensuring adherence to the anti-tuberculosis regimen, and the
methods of monitoring for adverse reactions.
(E) Except as set out in paragraph (A) of
this rule, the standard for methods of preventing individuals with tuberculosis
from infecting other individuals shall be as follows:
(1) Local tuberculosis
control units shall ensure that a complete and timely contact investigation is
done for tuberculosis cases reported in the area served by the
(2) Local tuberculosis
control units shall ensure that the services needed to evaluate, treat, and
monitor tuberculosis patients are made available in each community, without
regard to the patients' ability to pay for such services as specified in
section 339.73 of the Revised Code.
(F) Except as set out in paragraph (A) of
this rule, the standard for laboratories performing clinical tuberculosis
testing shall be as follows:
(1) Laboratories shall
hold a "Clinical Laboratory Improvement Act" (CLIA) certificate of
compliance or accreditation with a specialty in microbiology and a subspecialty
(2) Laboratories which do
not meet the criteria specified in this paragraph will be considered
unacceptable for the purpose of performing testing for
(3) Facilities which use
out-of-state laboratories shall be held accountable for ensuring that the
testing for tuberculosis meets the criteria as set out in this rule and in
paragraph (A) of rule 3701-15-02 of the Administrative Code.